#$%^&*AU2010226981A120120426.pdf#####17 Abstract Therapeutic compositions for the treatment of viral hepatitis B (HBV) and hepatitis C (HCV) comprise antistreptokinase and antistreptolysine antibodies and/or tranexamic acie. Three antibodies against: polymerase, plasmin activators and fibrin are found in the blood of hepatitis C infected patients.